# Watch: New Cancer Drugs from Artificial Life

By Troy Camplin · Published 2018-05-04 · Updated 2026-04-03 · Sciences on MarketScale
Canonical: https://www.marketscale.com/industries/sciences/watch-new-cancer-drugs-artificial-life

> In 2014 artificial life was made for the first time. Two new nucleotides were added—X and Y—to the standard four: A, G, T, C These new nucleotides allow for the addition of unnatural amino acids to create entirely new kinds of proteins. Now biotech company Synthorx has announced that they have developed a new cancer…

## Key points

- In 2014 artificial life was made for the first time.
- Two new nucleotides were added—X and Y—to the standard four: A, G, T, C These new nucleotides allow for the addition of unnatural amino acids to create entirely new kinds of proteins.
- Now biotech company Synthorx has announced that they have developed a new cancer…

In 2014 artificial life was made for the first time.

Two new nucleotides were added—X and Y—to the standard four: A, G, T, C

These new nucleotides allow for the addition of unnatural amino acids to create entirely new kinds of proteins.

Now biotech company Synthorx has announced that they have developed a new cancer drug using these artificial bacteria.

Interleukin-2 has been studied for decades as an immune system-stimulating cancer therapy, but it unfortunately comes with some serious side effects and is often unpredictable.

By adding an extra unnatural amino acid to Interleukin, Synthorx created a “*Synthorin*” that prolongs the protein’s activity while eliminating its immune-suppressing effects.

So, it turns out that creating artificial life is more than a cool laboratory trick—it may turn out to be a great new way to create new drugs as well.

Tags: [object Object]

---
Source: MarketScale, https://www.marketscale.com/industries/sciences/watch-new-cancer-drugs-artificial-life. Published for AI indexing and citation; cite the canonical URL. Site guide for agents: https://www.marketscale.com/llms.txt